Updated:
Linden Asset
Linden Asset invests in mobile internet, smart machinery, and biomedicine companies through venture capital and growth investments. The firm has made 11...
Linden Asset
Linden Asset invests in mobile internet, smart machinery, and biomedicine companies through venture capital and growth investments. The firm has made 11 investments, including a Series D - II investment in CH Biomedical on January 25, 2022. Linden Asset has a single portfolio exit, GenFleet Therapeutics, which occurred on September 19, 2025.
General information
Firm type
Private Equity
Year founded
2018
Location
Region
Asia
Country
China
City
Nanjing
Corporate office
Nanjing, China
Frequently asked questions
What investment stages does Linden Asset cover?
Linden Asset's mandate spans early-stage seed, start-up, expansion, and late-stage venture. This multi-stage structure allows the firm to invest across the full private company lifecycle without stage constraints.
Where is Linden Asset headquartered and where does it invest?
The firm is based in Nanjing, China. Its investment activity is focused on mainland China, consistent with the regional private equity and venture capital landscape.
Is Linden Asset a venture capital firm or a private equity firm?
Linden Asset operates as a private equity manager with a strategy that blends venture capital and growth equity. The firm invests from early-stage venture rounds through to expansion and late-stage private placements.
Does Linden Asset participate in fund commitments or only direct deals?
Based on the firm's classification and multi-stage direct-investment mandate, Linden Asset appears to focus on direct equity investments in portfolio companies rather than fund-of-funds commitments.
Who runs investment decisions at Linden Asset?
Names of the firm's managing principals and investment committee members are not publicly disclosed. The firm maintains a low public profile, which is common among regional direct-investment managers in China's private equity market.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: